Terms: = Liver cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
15 results:
1. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
[TBL] [Abstract] [Full Text] [Related]
2. ppm1d is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract] [Full Text] [Related]
3. Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract cancers.
Wu CE; Pan YR; Yeh CN; Lunec J
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33113997
[TBL] [Abstract] [Full Text] [Related]
4. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.
Cole AJ; Dickson KA; Liddle C; Stirzaker C; Shah JS; Clifton-Bligh R; Marsh DJ
Cell Mol Life Sci; 2021 Feb; 78(3):1011-1027. PubMed ID: 32458023
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients.
Puetkasichonpasutha J; Namwat N; Sa-Ngiamwibool P; Titapun A; Suthiphongchai T
Asian Pac J Cancer Prev; 2020 Mar; 21(3):791-798. PubMed ID: 32212809
[TBL] [Abstract] [Full Text] [Related]
6. Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma.
Xu Z; Cao C; Xia H; Shi S; Hong L; Wei X; Gu D; Bian J; Liu Z; Huang W; Zhang Y; He S; Lee NP; Chen J
Front Med; 2016 Mar; 10(1):52-60. PubMed ID: 26809466
[TBL] [Abstract] [Full Text] [Related]
7. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting wip1.
Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
[TBL] [Abstract] [Full Text] [Related]
8. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
Dogra S; Bandi S; Viswanathan P; Gupta S
Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910
[TBL] [Abstract] [Full Text] [Related]
9. [Mechanism study on anti-proliferative effects of curcumol in human hepatocarcinoma HepG2 cells].
Huang LZ; Wang J; Lu FT; Yang FC; Chen X; Hong X; Jiang XS
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1812-5. PubMed ID: 24010301
[TBL] [Abstract] [Full Text] [Related]
10. Expression and significance of the wip1 proto-oncogene in colorectal cancer.
Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
[TBL] [Abstract] [Full Text] [Related]
11. Protein phosphatase magnesium-dependent 1δ (ppm1d) mRNA expression is a prognosis marker for hepatocellular carcinoma.
Li GB; Zhang XL; Yuan L; Jiao QQ; Liu DJ; Liu J
PLoS One; 2013; 8(3):e60775. PubMed ID: 23556002
[TBL] [Abstract] [Full Text] [Related]
12. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
Meng XZ; Zheng TS; Chen X; Wang JB; Zhang WH; Pan SH; Jiang HC; Liu LX
J Gastroenterol Hepatol; 2011 Jan; 26(1):186-93. PubMed ID: 21175813
[TBL] [Abstract] [Full Text] [Related]
13. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
Yang F; Yin Y; Wang F; Wang Y; Zhang L; Tang Y; Sun S
Hepatology; 2010 May; 51(5):1614-23. PubMed ID: 20209605
[TBL] [Abstract] [Full Text] [Related]
14. Hepatocellular adenoma: cost-effectiveness of different treatment strategies.
van der Sluis FJ; Bosch JL; Terkivatan T; de Man RA; Ijzermans JN; Hunink MG
Radiology; 2009 Sep; 252(3):737-46. PubMed ID: 19717753
[TBL] [Abstract] [Full Text] [Related]
15. MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers.
Kanai Y; Ushijima S; Saito Y; Nakanishi Y; Sakamoto M; Hirohashi S
J Cancer Res Clin Oncol; 2001 Dec; 127(12):697-706. PubMed ID: 11768609
[TBL] [Abstract] [Full Text] [Related]
